Overview

Double Blind Study of Trp01 in Patients With Alzheimer's Disease

Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether tryptophan is effective in the treatment of mild to moderate Alzheimer's Disease (AD).
Phase:
Phase 4
Details
Lead Sponsor:
Queen's University
Treatments:
Tryptophan